Bacterial pyrophosphates or aminobisphosphonates induce cytokine secretion and expansion of freshly isolated (resting) human V 9V 2 T cells. The initial expansion of T cells strictly depends on co-stimulatory signals of accessory cells and IL-2. However, resting T cells produce cytokines after stimulation with pyrophosphates combined with TLR3 ligand poly(I:C) in the absence of accessory cells. We observed that aminobisphosphonate together with poly(I:C) stimulation did not induce cytokine secretion in resting T cells. Moreover, proliferation of T cells within PBMC was enhanced after stimulation with pyrophosphates and poly(I:C), but not after stimulation with aminobisphosphonates plus poly(I:C), even though accessory cells were present. Aminobisphosphonate together with poly(I:C) induced a delayed up-regulation of co-stimulatory molecules and cell survival of monocytes within PBMC. In contrast to resting T cells, activated V 9V 2 T cells produced IFN-after stimulation with pyrophosphate antigens as well as with aminobisphosphonate in the absence of accessory cells and poly(I:C). However, aminobisphosphonate stimulation resulted in much lower IFN-production than pyrophosphate stimulation, which fits well with the weaker aminobisphosphonate induced activation of extracellular regulated kinase (ERK) involved in IFN-secretion. Poly(I:C) failed to enhance cytokine production and proliferation of activated T cell lines after aminobisphosphonate stimulation unless accessory cells were added. Taken together, the results suggest a differential regulation of V 9V 2 T cell activation by pyrophosphates and aminobisphosphonates, especially after co-stimulation with poly(I:C). This might be relevant when using such pyrophosphates or aminobisphosphonates together with TLR3 agonists as adjuvants in T cell-based immunotherapy.
INTRODUCTION
Peripheral blood V 9V 2 T cells exert their potent effector function against various bacteria, viruses and tumours by the release of pro-inflammatory cytokines and cytotoxic mediators [1, 2] . Several pilot studies described T cells as a promising strategy for immunotherapy due to their potent MHC-nonrestricted cytotoxicity [3] [4] [5] [6] . Activation and expansion of V 9V 2 T cells is stimulated by the recognition of small phosphorylated intermediates (such as (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate, HMBPP) of the desoxyxylulose-5-phosphate (DOXP) isoprenoid biosynthesis pathway of non-mammalian cells (so called phosphoantigens, PAg) [7] . In contrast, the mevalonate isoprenoid pathway-derived Isopentenylpyrophosphate (IPP) produced by mammalian cells does not activate V 9V 2 T cells at concentrations that are produced in physiological non-transformed cells [8] . However, the inhibition of farnesyl diphosphate (FPP) synthase, an IPP-processing enzyme of the eukaryotic isoprenoid pathway, results in an accumulation of the substrates of FPP synthase, IPP and its stereoisomer dimethylallyl diphosphate (DMAPP), then leading to V 9V 2 T cell expansion [9, 10] . Inhibitors of the FPP synthase include aminobisphosphonates (e.g. pamidronate, zolendronate or alendronate) and alkylamines [11, 12] . Aminobisphosphonates (nitrogen-containing bisphosphonates, N-BPs) prevent the biosynthesis of isoprenoid lipids required for the prenylation of small GTPases, which result e.g. in an abolishment of pathological bone-resorption through osteoclasts in osteoporosis patients [13] . N-BPs are licensed drugs for the treatment of osteoporosis, and tumourassociated bone diseases and carry perspectives for T cellbased immunotherapy [14] [15] [16] . Roelofs and colleagues have shown that the accumulation of IPP/DMAPP in peripheral blood monocytes or in tumour cells with a dysregulated mevalonate pathway is responsible for the V 9V 2 T cell activation [10] . The stimulation of PBMC with PAgs or NBPs results in a release of cytokines including IFN-, TNFand IL-6 and in the presence of IL-2 in a selective expansion of T cells [17, 18] . In addition to the activation of V 9V 2 T cells by PAgs and N-BPs, other cell surface molecules such as activating natural killer receptor NKG2D (CD314) and Toll-like receptor (TLR) 3 modulate the effector function of T cells [18, 19] . NKG2D binds to stress-inducible MHC class I-chain-related antigens (MIC) A/B as well as UL16-binding proteins (ULBP) 1-4 inducibly expressed on peripheral blood monocytes or constitutively on tumour cells, and deliver stimulatory signals [19] [20] [21] [22] . On the other side, TLR have been identified as primary sensors of bacterial and viral components leading to the production of pro-inflammatory cytokines and chemokines, upregulation of co-stimulatory molecules, enhanced proliferation and regulation of cell survival as well as apoptosis [23] [24] [25] . We and others previously reported that both the NKG2D/NKG2DL-and the TLR3/TLR3L-pathway positively affect the activation of freshly isolated T cells and modulate the cytotoxic activity of activated V 9V 2 T cells [18, 19, 26] .
In this report, we examined whether TLR3, the receptor for dsRNA, which can be mimicked by the surrogate ligand poly(I:C), induces a co-stimulatory signal in N-BP stimulated T cells comparable to the observed results with PAg-stimulated cells. We describe a differential outcome of PAg-versus N-BP-stimulation in the presence of poly(I:C), which should be considered as relevant when using such drugs as selective activators in T cell based immunotherapy.
MATERIALS AND METHODS

Isolation of Cells and Establishment of
T Cell Lines. PBMC were isolated from buffy coats from healthy adult blood donors by Ficoll-Hypaque (Biochrom, Berlin, Germany) density gradient. Buffy coats were obtained from the Department of Transfusion Medicine in Kiel/Lübeck, Germany. Informed consent was obtained from all donors and research was approved by the relevant institutional review boards.
T cells were negatively separated from freshly isolated PBMC using T cell receptor (TCR) / T Cell Isolation Kits (Miltenyi Biotec, Bergisch-Gladbach, Germany). For negative selection, the non-T cells within PBMC were indirectly stained with a cocktail of biotinylated monoclonal anti-human antibodies against antigens not expressed by T cells followed by anti-biotin microbeads. To improve T cell purity after magnetic separation and to eliminate residual non-T cells by sorting the cells with a FACS Aria (BD Biosciences), enriched T cells were stained with a cocktail of the following mAbs: pan anti-TCR BMA031 (Beckman Coulter, Krefeld, Germany), anti-CD19, anti-CD56, anti-CD14 (all from BD Biosciences, Heidelberg, Germany), anti-CD303 (BDCA-2) and CD141 (BDCA-3) (both from Miltenyi Biotec). 
Measurement of T Cell Expansion. Proliferation was analyzed by uptake of [
3 H]-thymidine incorporation after 6 to 9 days of culture. Microculture wells with 10 5 stimulated PBMC were pulsed during the last 16 hours of a 6 to 9-day culture with 1 Ci [
3 H]-TdR per well (sp. act.: 5 Ci/mmol; GE Healthcare, München, Germany). Cell cultures were harvested onto filtermats and radioactivity was determined by a Wallac 1450 Microbeta -counter (Perkin Elmer, Rodgau, Germany). The absolute cell number of expanded T cells was measured by a previously developed flow cytometric method termed standard cell dilution assay (SCDA) [27, 28] . Briefly, cultured cells were incubated with PE-labelled anti-TCR V 2 mAb (BD Biosciences). After being washed, cells were resuspended in 100 l sample buffer containing a constant number (10 5 /ml) standard cells and 0.2 g/ml propidium iodide (PI; Sigma, Taufkirchen, Germany) to exclude dead cells. Flow Cytometry. To characterize the CD69 expression on the surface of T cells, negatively isolated T cells were stained before and after stimulation with antigens with anti-CD69 mAb or the appropriate isotype control (both from BD Biosciences).
To determine the expression of co-stimulatory molecules or NKG2D ligands on CD14 + monocytes, the following mAb were used: PE-conjugated anti-CD80, PE-labelled anti-CD86 (all from BD Biosciences), unconjugated ULBP-2 or ULBP-3, (R&D Systems) followed by PE-conjugated goat F(ab´) 2 anti-mouse IgG (Invitrogen, Karlsruhe, Germany) as a second step reagent or the corresponding isotype controls combined with staining with FITC-labelled anti-CD14 mAb. A gate was set on the CD14 + monocytes within the PBMC to analyze the expression of the co-stimulatory molecules or NKG2D ligands on CD14 + monocytes.
For cell death analysis of monocytes, PBMC were stained with FITC-conjugated anti-CD14 mAb after 24 and 48 hours and after 6-9 days of culture, washed and resuspended in buffer containing 2.5 g/ml PI. A gate was set on the CD14 + monocytes within the PBMC to determine CD14 + PI + cells. All samples were measured on a FACSCalibur (BD Biosciences) using the CellQuestPro software.
Phospho-ERK1/2 Western Blot.
T cell lines were stimulated in the absence or presence of autologous CD14 + monocytes with 5 g/ml anti-CD3 mAb OKT3 cross-linked with 1.7 g/ml rabbit-anti-mouse (ram), 500 nM BrHPP or 50 M alendronate for the indicated timepoints. Cells were lysed in Nonidet P40 lysis buffer (Fluka Chemie, Buchs, Switzerland). The lysis buffer contains 1% (v/v) of detergent in 20 mM Tris-HCL (pH 8.1) and 50 mM NaCl with phosphatase and protease inhibitors. After complete denaturation, samples were separated on 10% SDS-PAGE, and proteins were transferred to nitrocellulose membranes (Hybond-C-Extra, GE Healthcare). Blots were blocked with BSA (Sigma-Aldrich), stained with phosho-ERK1/2 mAb (Cell Signaling, Frankfurt, Germany) followed by HRPconjugated donkey anti-rabbit antibody (GE Healthcare) and analyzed with chemiluminescence reagent (ECL, GE Healthcare).
Statistical Analysis. The paired, two-tailed Student´s tTest was performed where applicable.
RESULTS
Poly(I:C) Increases CD69 Expression and IFN-
Production of PAg-Activated-but not of N-BP-Activated T Cells. We recently observed that CD69 expression on highly purified, positively selected T cells was slightly increased when cells were cultured for 24 hours in medium alone [18] . This effect seemed to be mediated by the mitogenic effect of the pan TCR mAb clone 11F2, which was used for the positive selection of T cells. As shown in Fig. (1) , CD69 expression was not enhanced on negatively isolated T cells from healthy donors when cells were cultured for 24 hours in medium alone. In line with the results with positively isolated T cells, CD69 expression (Fig. 1A) and IFN-production (Fig. 1B) were up-regulated after TCR activation with the PAg BrHPP (200 nM) and further up-regulated in the presence of 50 g/ml poly(I:C), whereas poly(I:C) alone did not induce CD69 expression and IFN-production. This confirmed our recent data that poly(I:C) has a co-stimulatory effect on TCR-activated freshly isolated T cells [18] . Moreover, the experiments clearly show that the co-stimulatory effect was independent of the isolation procedure of T cells. We also investigated whether other T cell-activating reagents such as the N-BP alendronate also induced IFN-production in T cells in the presence of poly(I:C) and absence of accessory cells as PAg stimulation did. We observed that the stimulation of negatively isolated T cells for 24 hours with alendronate did not enhance CD69 expression or IFN-expression on purified T cells and was not further modulated by the addition of poly(I:C) (Fig. 1A, B) . 
Differential Responses of T Cell Lines to PAg or N-BP in the Presence of poly(I:C).
We also compared the response of freshly isolated T cells and activated T cell lines to PAg and N-BP in the presence of poly(I:C). In contrast to freshly isolated T cells, N-BP-activated T cell lines produced slightly increased levels of IFN-in the absence of accessory cells (e.g. monocytes/macrophages) as compared to the medium control ( Fig. 2A) . While an elevated level of IFN-produced by PAg-stimulated T cell lines was further enhanced in the presence of poly(I:C), IFN-production of N-BP-stimulated T cell lines was not increased with poly(I:C) in the absence of monocytes/ macrophages ( Fig. 2A) . However, co-culture of these T cell lines with monocytes/macrophages resulted in a slightly enhanced IFN-production compared to parallel culture experiments without accessory cells. (Fig. 2A, B) . Moreover, we observed a minor up-regulation of IFN-production in the presence of poly(I:C) even without TCR stimulus, which seems to be caused by the pre-activated state of the T cell lines (Fig. 2B) . In line with the weak responsiveness of T cell lines to N-BP in the absence of accessory cells, we observed that unless accessory cells were added, alendronate only mildly activated the extracellular regulated kinase (ERK)1/2 (Fig. 3A, B ) and p38 (data not shown), two mitogen-activated protein kinases involved in the TCRstimulated IFN-secretion. However, under these conditions monocytes alone seem to induce MAP kinase ERK1/2 after N-BP stimulation, making it difficult to distinguish the ERK1/2 activation in the co-culture of T cell lines and CD14 + monocytes. As a positive control for phosphorylation of ERK1/2 in T cell lines, we used stimulation with anti-CD3 mAb OKT3 cross-linked with rabbit-anti-mouse or BrHPP, respectively. As expected, anti-CD3 as well as BrHPP induced an activation of MAP-kinases in T cell lines (Fig. 3) . In contrast, we found that alendronate did not induce activation-induced cell death in T cell lines (data not shown). Of note, we previously published that proliferation of BrHPP-stimulated T cell lines was increased in the presence of poly(I:C) in the absence of accessory cells [18] , whereas N-BP-stimulated T cell lines failed to proliferate under these conditions unless accessory cells were present (data not shown).
PAg-versus N-BP-Induced
T Cell Proliferation with poly(I:C) Might be Due to Differential Effects on Cell Death and Co-Stimulatory Molecules. On the basis of necessity of accessory cells for N-BP induced T cell cytokine production and proliferation, we used PBMC in the following experiments. As expected, PBMC proliferated after stimulation with BrHPP or alendronate in the presence of exogenous IL-2 and in the absence of poly(I:C). Surprisingly, we observed that the proliferation was enhanced after BrHPP stimulation by adding poly(I:C), whereas proliferation was reduced when alendronate stimulation was combined with poly(I:C) (Fig. 4A) . BrHPP selectively activates T cells, but alendronate and poly(I:C) could also stimulate accessory cells. Since the 3 [H]-TdR incorporation does not allow direct measurements of proliferating subpopulations, the expansion of T cells within PBMC was analyzed using the SDCA method. By determining the absolute cell numbers, we could demonstrate that V 9 + T cells expand after BrHPP or alendronate stimulation (Fig. 4B) . Moreover, we determined that the presence of poly(I:C) increased the BrHPP-but decreased the N-BP-stimulated proliferation of V 9 + T cells (Fig.  4B) .The increased proliferation could be explained by a direct effect of BrHPP and poly(I:C) on TLR3-expressing T cells and an additional indirect effect of TLR3-expressing CD11c + CD1c + myeloid dendritic cells producing e.g. type-I-interferons within PBMC. This goes in line with the previous notion that, in contrast to PAg, N-BP indirectly stimulate T cell proliferation by activating monocytes/ macrophages [10] to produce significantly more PAg IPP/DMAPP. Of note, we observed an increased cell death after 7 days of culturing CD14 + monocytes/ macrophages with N-BP alendronate (Fig. 5A) , which suggests that accumulated IPP/DMAPP is released only after cell death of monocytes/macrophages and then binds and activates T cell was activated with 5 g/ml OKT3 crosslinked with 1.7 g/ml rabbitanti-mouse (ram). MAPK activity was analyzed in total cell lysates and Western blotting using polyclonal rabbit anti-phospho-ERK1/2 antibodies. Data of one representative experiment out of six are shown.
T cells. Moreover, we observed that poly(I:C) prevents cell death of monocytes/macrophages under these conditions (Fig. 5A) and thus possibly also the release of T cellstimulating IPP/DMAPP. Notably, TLR3 expression was nearly absent in CD14 + monocytes/macrophages [18] , but was up-regulated after stimulation [29] . In comparison to poly(I:C) stimulation alone, alendronate plus poly(I:C) induced a delayed up-regulation of co-stimulatory molecules such as CD80, CD86, ULBP-2 and ULBP-3 on CD14 + monocytes/ macrophages. This could also account for the reduced T cell proliferation after stimulation of PBMC with alendronate and poly(I:C) (Fig. 5B) .
DISCUSSION
In the present study, we demonstrate a differential regulation of V 9V 2 + T cell-activation by PAg and N-BP in the presence of poly(I:C). We previously reported a direct co-stimulatory effect of poly(I:C) on the CD69 expression and IFN-production of PAg-stimulated positively isolated T cells [2, 18] . These data were confirmed with negatively isolated T cells. In contrast to this co-stimulatory effect of PAg, we demonstrate here that 
